<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Cincinnati&#8217;s Akebia Therapeutics races (as safely as possible) toward new anemia treatment</title>
	<atom:link href="http://www.medcitynews.com/2009/10/at-akebia-the-race-is-on/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.medcitynews.com/2009/10/at-akebia-the-race-is-on/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=at-akebia-the-race-is-on</link>
	<description>MedCity News</description>
	<lastBuildDate>Sat, 11 Feb 2012 15:17:29 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
	<item>
		<title>By: Akebia completes Phase I trial of anemia drug : MedCity News</title>
		<link>http://www.medcitynews.com/2009/10/at-akebia-the-race-is-on/comment-page-1/#comment-49165</link>
		<dc:creator>Akebia completes Phase I trial of anemia drug : MedCity News</dc:creator>
		<pubDate>Tue, 05 Jan 2010 19:47:49 +0000</pubDate>
		<guid isPermaLink="false">http://www.medcitynews.com/?p=11685#comment-49165</guid>
		<description>[...] was born three years ago when Procter &amp; Gamble began dismantling its pharmaceuticals division. Joseph Gardner, a former [...]</description>
		<content:encoded><![CDATA[<p>[...] was born three years ago when Procter &amp; Gamble began dismantling its pharmaceuticals division. Joseph Gardner, a former [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Cincinnatiâ€™s Akebia Therapeutics races (as safely as possible) toward new anemia treatment &#124; DIALED-IN</title>
		<link>http://www.medcitynews.com/2009/10/at-akebia-the-race-is-on/comment-page-1/#comment-30820</link>
		<dc:creator>Cincinnatiâ€™s Akebia Therapeutics races (as safely as possible) toward new anemia treatment &#124; DIALED-IN</dc:creator>
		<pubDate>Mon, 19 Oct 2009 16:54:34 +0000</pubDate>
		<guid isPermaLink="false">http://www.medcitynews.com/?p=11685#comment-30820</guid>
		<description>[...] Via MedCity News [...]</description>
		<content:encoded><![CDATA[<p>[...] Via MedCity News [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Weekend Rounds: Innovation in anemia and vascular drugs, insulin : MedCity News</title>
		<link>http://www.medcitynews.com/2009/10/at-akebia-the-race-is-on/comment-page-1/#comment-30235</link>
		<dc:creator>Weekend Rounds: Innovation in anemia and vascular drugs, insulin : MedCity News</dc:creator>
		<pubDate>Sat, 17 Oct 2009 13:59:39 +0000</pubDate>
		<guid isPermaLink="false">http://www.medcitynews.com/?p=11685#comment-30235</guid>
		<description>[...] for anemia and a way to prevent some heart-related side-effects during cancer treatment. Now, Akebia is racing competitors to the market (as safely as possible) with its anemia drug. There seems to be event more excitement [...]</description>
		<content:encoded><![CDATA[<p>[...] for anemia and a way to prevent some heart-related side-effects during cancer treatment. Now, Akebia is racing competitors to the market (as safely as possible) with its anemia drug. There seems to be event more excitement [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Akebia&#8217;s second act: Coming in 2012 : MedCity News</title>
		<link>http://www.medcitynews.com/2009/10/at-akebia-the-race-is-on/comment-page-1/#comment-29198</link>
		<dc:creator>Akebia&#8217;s second act: Coming in 2012 : MedCity News</dc:creator>
		<pubDate>Wed, 14 Oct 2009 18:15:15 +0000</pubDate>
		<guid isPermaLink="false">http://www.medcitynews.com/?p=11685#comment-29198</guid>
		<description>[...] Ohio &#8212; Akebia Therapeutics is furthest along on an anemia pill that the company hopes will take the place of hormone injections. But there seems to be event more [...]</description>
		<content:encoded><![CDATA[<p>[...] Ohio &#8212; Akebia Therapeutics is furthest along on an anemia pill that the company hopes will take the place of hormone injections. But there seems to be event more [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk
Page Caching using disk (enhanced)

Served from: www.medcitynews.com @ 2012-02-12 23:23:15 -->
